#China #Shanghai #CPHI #PMEC

CPHI & PMEC China 2025: Redefining Pharmaceutical Trade

The highly anticipated CPHI & PMEC China exhibition will take place from June 24 to June 26, 2025, at the Shanghai New International Expo Center. This event marks a significant resurgence in global interest in the pharmaceutical manufacturing sector and is poised to become the largest pharmaceutical gathering ever held in Asia, with expectations of over 90,000 attendees and more than 12,000 international business leaders.

A striking feature driving this year's exhibition is the record international participation. This increase comes amidst a positive outlook in global trade dynamics and pharmaceutical investments, largely influenced by reduced trading tariffs. Such changes are fostering growth not just within China but across the entire global pharmaceutical landscape.

Attracting 3,500 exhibitors from 150 countries, the exhibition will span over 230,000 square meters and introduce 12 thematic zones, including new focal areas like ‘BioTech’ and ‘Fluid Precision Equipment.’ According to Natasha Jennings, Head of Global Marketing Growth, this event will serve as a pivotal platform where international participants can tap into the extensive network of Chinese ingredient manufacturers, equipment providers, and resource suppliers to leverage global production expansion.

In recent years, Western pharmaceutical companies have shown increasing interest in partnering with Chinese biotech firms—not only as a means of accessing the domestic market but also for global licensing opportunities. Meanwhile, nations in the Middle East are ramping up their participation as they strive to create regional manufacturing hubs in collaboration with larger stakeholders in India and the United States. This trend could play a crucial role in reshaping the pharmaceutical supply chain dynamics.

Moreover, the engagement level at the event is exceptionally high, with 80% of international participants holding procurement authority and over 50% occupying executive positions. This showcases the strategic importance of the event for decision-makers in the industry. Additional programs include Natural Extracts Buyers Program (on June 23) and Pharmaceutical Equipment Buyers Program (from June 24-25), alongside the prestigious CPHI Celebration Awards ceremony and thematic conferences such as the 10th Biopharmaceuticals Outlook Summit.

The event underscores a revitalized global pharmaceutical partnership as companies aim to expand their networks and strengthen connections with primary, secondary, and backup suppliers for strategic planning. Jennings further indicates that the improving trade relations are fostering renewed collaboration across the pharmaceutical sector.

As the industry bounces back with robust indicators of growth, CPHI & PMEC China 2025 promises to be the centerpiece of this thriving ecosystem, offering ample opportunities for networking, innovation, and business growth in the ever-evolving pharmaceutical landscape. Interested participants can register for the event via the official website CPHI China Registration. The excitement surrounding the event reflects a pivotal moment in the global pharmaceutical trade and highlights the ongoing evolution within this critical industry.